VVOS · Vivos Therapeutics, Inc.
$0.30
-0.04 (-11.94%)
At close · Aug 17
Going-concern doubt
— flagged Aug 14, 2026
Substantial doubt about the company's ability to continue as a going concern.
“Without additional financing, these factors raise substantial doubt regarding the Company's ability to continue as a going concern.”View the 10-Q filed Aug 14, 2026
Market Cap
$6.91M
Shares
20.12M
Registered funds — mutual funds, ETFs and closed-end funds — whose latest Form N-PORT portfolio report holds this stock, matched by the stock's CUSIP. Each row is one fund position with its size, value and weight in that fund.
Funds holding VVOS
5 fund positions| Fund | Ticker | Balance | Value | % of Fund | Side | Reported | Open |
|---|---|---|---|---|---|---|---|
| VANGUARD TOTAL STOCK MARKET INDEX FUND | — | 212,700 | $250,986 | 0.00% | Long | 2026-03-31 | |
| VANGUARD EXTENDED MARKET INDEX FUND | — | 60,629 | $71,542 | 0.00% | Long | 2026-03-31 | |
| Fidelity Extended Market Index Fund | — | 60,769 | $42,538 | 0.00% | Long | 2026-05-31 | |
| Fidelity Total Market Index Fund | — | 12,072 | $8,450 | 0.00% | Long | 2026-05-31 | |
| Fidelity Series Total Market Index Fund | — | 8,350 | $5,845 | 0.00% | Long | 2026-05-31 |
Showing 1–5 of 5 positions
Key facts
CIK
1716166
CUSIP
92859E207
13F (30d)
21 filings
21 filers
Visit website
Investor relations